Abstract
Abstract
This study investigates South Korea's trials and errors in procuring COVID-19 vaccines from abroad, amid the limitations of a multilateral scheme for global provision through the COVID-19 Vaccines Global Access (COVAX) program via the World Health Organization (WHO) and the discussions on COVID-19 vaccine patent waivers at the World Trade Organization. Using the framework of “self-help” in the international system and country categorization to explicate country behaviors by state-business relations and expertise to explain South Korea's COVID-19 vaccine procurement process, this study argues that in the absence of a global mechanism that guarantees adequate and timely vaccine provision, countries are left to the sole option of depending on their own capabilities: expertise, budget, and policy planning by consolidating public and private capacities to acquire vaccines for the public. To support the argument, an in-depth case investigation of South Korea's Vaccine Procurement Task Force is presented. The case study focuses on the policy assessment of critical elements in South Korea's vaccine procurement and rollout on facing obstacles to sufficient procurement through COVAX: decision-making impacting the timing and dosage of procurement, diplomatic and business channels to sign bilateral contracts, setup of a smart-factory vaccination hub, and indigenous vaccine development for WHO approval.
Reference91 articles.
1. Preparing for a Pandemic: Accelerating Vaccine Availability;Ahuja,2021
2. Banco
Erin
, FurlongAshleigh, and PfahlerLennart. 2022. “How Bill Gates and Partners Used Their Clout to Control the Global COVID Response—with Little Oversight.” Politico, September14. https://www.politico.com/news/2022/09/14/global-covid-pandemic-response-bill-gates-partners-00053969.
3. Berkley
Seth
. 2020. “COVAX Explained.” Global Alliance for Vaccines and Immunization, September3. https://www.gavi.org/vaccineswork/covax-explained.
4. COVID-19 Is a Crisis in Planetary Health and Politics of Expertise: Time to Think Critically and Innovate Both;Boschele;OMICS: A Journal of Integrative Biology,2021
5. How COVID-19 Vaccine Supply Chains Emerged in the Midst of a Pandemic;Bown,2021